Caption Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Caption Management's GILD Position: Q2 2026 in Review
Caption Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 100,000 shares worth $12.6M. The stake represents 0.06% of the portfolio and ranks #338 among its holdings. This is a return to the name: Caption Management previously reported a position in GILD as recently as Q3 2025.
Caption Management first reported a position in GILD in Q3 2019 and has held it in 10 quarters since. The position peaked at $16.5M in Q2 2025. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Caption Management held 100,000 shares of Gilead Sciences worth $12.6M as of Q2 2026.
- Gilead Sciences was a new Caption Management position in Q2 2026.
- Gilead Sciences made up 0.06% of Caption Management's portfolio in Q2 2026, its #338 holding.
- Caption Management first reported a position in Gilead Sciences in Q3 2019 and has held it in 10 quarters since.
- Caption Management's Gilead Sciences position peaked at $16.5M in Q2 2025.
- 2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.